Cardlytics (CDLX) R&D/CAPEX US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 173.3% | 303.3% | 408.9% | 403.6% | 414.4% | 228.0% | |||
Changes by years, y/y, % | +67pp | +130pp | +106pp | -5pp | +11pp | +13.4% |
Cardlytics. R&D/CAPEX, %
Cardlytics. R&D/CAPEX, changes, pp
Cardlytics (CDLX) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
R&D/CAPEX, % | 395.1% | 338.4% | 274.9% | 277.3% | 137.4% | 228.0% | ||
Changes by years, y/y, % | -21pp | -131pp | -164pp | -263pp | -258pp | |||
Changes by quarters, q/q, % | -145pp | -57pp | -64pp | +2pp | -140pp |